-
Subject Areas on Research
-
Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients.
-
Aerosol and other novel administrations for prevention and treatment of invasive aspergillosis.
-
An Infection Control Program for a 2009 influenza A H1N1 outbreak in a university-based summer camp.
-
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation.
-
Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data.
-
Broad spectrum triazoles for invasive mould infections in adults: Which drug and when?
-
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.
-
Chemoprevention for gastric cancer.
-
Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.
-
Chemoprevention of pancreatic cancer: ready for the clinic?
-
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.
-
Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis.
-
Combined effect of chemopreventive agent N-(4-hydroxyphenyl) retinamide (4-HPR) and gamma-radiation on bladder cancer cell lines.
-
Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire.
-
Dihydropteroate synthase mutations in Pneumocystis pneumonia: impact of applying different definitions of prophylaxis, mortality endpoints and mutant in a single cohort.
-
Do Histopathology and Clinical Outcomes of Breast Atypia Vary by Race/Ethnicity?
-
Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective?
-
ESR1 promoter hypermethylation does not predict atypia in RPFNA nor persistent atypia after 12 months tamoxifen chemoprevention.
-
Early Chemoprophylaxis Against Venous Thromboembolism in Patients With Traumatic Brain Injury.
-
Early prostate cancer: prevention, treatment modalities, and quality of life issues.
-
Echinocandins: a wealth of choice--how clinically different are they?
-
Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants.
-
Effect of three years' seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali.
-
Evaluation and management of fungal infections in immunocompromised patients.
-
Evolution of heparin anticoagulants to ultra-low-molecular-weight heparins: a review of pharmacologic and clinical differences and applications in patients with cancer.
-
Global prevention of HIV infection for neglected populations: men who have sex with men.
-
HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness.
-
Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a Thing.
-
Impact of Economic, Regulatory and Patent Policies on Innovation in Cancer Chemoprevention
-
In-Hospital Outcomes and Discharge Medication Use Among Patients With Critical Limb Ischemia Versus Claudication.
-
Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention.
-
Intermittent preventive treatment for malaria in infants: moving forward, cautiously.
-
Invasive mould infections: a multi-disciplinary update.
-
Is Excisional Biopsy and Chemoprevention Warranted in Patients With Atypical Lobular Hyperplasia on Core Biopsy?
-
Low Risk of Proximal Tubular Dysfunction Associated With Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in Men and Women.
-
Low incidence of symptomatic thromboembolic events after total ankle arthroplasty without routine use of chemoprophylaxis.
-
Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial.
-
Lung cancer chemoprevention: ACCP evidence-based clinical practice guidelines (2nd Edition).
-
Malaria: a rising incidence in the United States.
-
Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
-
New Developments in the Management of Cutaneous Squamous Cell Carcinoma.
-
Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices.
-
Overview of treatment options for invasive fungal infections.
-
Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report.
-
Partnerships Between a University-Affiliated Clinic and Community-Based Organizations to Reach Black Men Who Have Sex With Men for PrEP Care.
-
Perceptibility and the "Choice Experience": User Sensory Perceptions and Experiences Inform Vaginal Prevention Product Design.
-
Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP.
-
Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant.
-
Pharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation.
-
Prevention of lung cancer: summary of published evidence.
-
Problematic End Points in a Trial of Topical Fluorouracil, 5%, for Chemoprevention of Keratinocyte Carcinoma-Reply.
-
Prophylactic colony-stimulating factors in children receiving myelosuppressive chemotherapy: a meta-analysis of randomized controlled trials.
-
Rapamycin for chemoprevention of upper aerodigestive tract cancers.
-
Reasons for Refusal of Newborn Vitamin K Prophylaxis: Implications for Management and Education.
-
Reply to Verweij et al.
-
Scoring system for risk stratification of viral reactivation during prophylactic antiviral treatment in Korean patients with hepatitis B undergoing anticancer chemotherapy: A multicenter study.
-
Statins and cancer risk: what do we know and where do we go from here?
-
Strategies to manage the HIV epidemic in gay, bisexual, and other men who have sex with men.
-
The epidemiology and diagnosis of invasive candidiasis among premature infants.
-
The potential uses of preexposure prophylaxis for HIV prevention among people who inject drugs.
-
The rational design and development of a dual chamber vaginal/rectal microbicide gel formulation for HIV prevention.
-
Unrelated donor umbilical cord blood transplantation in pediatric myelodysplastic syndrome: a single-center experience.
-
Use of vitamins, minerals, and nutritional supplements by participants in a chemoprevention trial.
-
Venous thromboembolism among patients hospitalized with COVID-19 at Veterans Health Administration Hospitals.
-
Keywords of People
-
Cohen-Wolkowiez, Michael,
Professor of Pediatrics,
Pediatrics, Infectious Diseases
-
Halabi, Susan,
Professor of Biostatistics & Bioinformatics,
Biostatistics & Bioinformatics
-
Moorman, Patricia Gripka,
Professor Emeritus in Family Medicine and Community Health,
Duke Cancer Institute
-
O'Meara, Wendy P,
Associate Professor of Medicine,
Medicine, Infectious Diseases
-
Reed, Shelby Derene,
Professor in Population Health Sciences,
Duke Science & Society
-
Tsalik, Ephraim,
Adjunct Associate Professor in the Department of Medicine,
Medicine, Infectious Diseases